• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Reva Medical Inc.

Reva Medical files for bankruptcy

January 15, 2020 By Sean Whooley

Reva Medical (ASX:RVA) announced today that it has filed for Chapter 11 bankruptcy protection. San Diego-based Reva — which specializes in bioresorbable polymer tech for vascular applications — entered into a restructuring support agreement with a handful of its stakeholders last month. The goal was to address the company’s outstanding debt. Reva also filed a prepackaged […]

Filed Under: Business/Financial News, Funding Roundup, Pharmaceutical, Vascular Tagged With: Bankruptcy, Reva Medical Inc.

7 women in medtech you should know

March 8, 2019 By Danielle Kirsh

Women hold more executive leadership roles in the medtech industry today than they did 20 years ago, but there’s still a long way to go. There is still a women’s leadership gap in the U.S., though. According to a report from the Centers for American Progress, women hold 52% of professional jobs in the U.S. […]

Filed Under: Blog Tagged With: Aris MD, Digital Cognition Technologies, Eastman Chemical, Fresenius, GE Healthcare, Medtronic, Reva Medical Inc., Women in Medtech

Reva Medical cuts 44% of workforce

February 5, 2019 By Sarah Faulkner

Reva Medical (ASX:RVA) said this week that it plans to cut its workforce by 44%, leaving 22 employees at the San Deigo-based company. In a statement, Reva CEO Reggie Groves cited current market conditions as the primary reason for the staffing reduction. Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Pharmaceutical, Vascular, Wall Street Beat Tagged With: Reva Medical Inc.

Reva brings bioresorbable scaffolds to new markets

January 9, 2019 By Sarah Faulkner

Reva Medical (ASX:RVA) said this week that it inked four new distribution agreements, bringing its commercial operations to seven European countries. The San Diego, Calif.-based company said the deals serve to expand the reach of its drug-eluting bioresorbable scaffold, Fantom Encore. Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Business/Financial News, Distribution, Drug-Device Combinations, Featured, Pharmaceutical, Vascular, Wall Street Beat Tagged With: Reva Medical Inc.

Insulet taps former Medtronic finance exec McMillan as CFO | Personnel Moves – January 8, 2019

January 8, 2019 By Fink Densford

Insulet (NSDQ:PODD) said yesterday that it tapped former Medtronic minimally invasive therapies CFO and finance VP Wayde McMillan as its new chief financial officer, replacing Michael Levitz. The Acton, Mass.-based diabetes-focused medtech company said that McMillan will join the company in February and that Levitz will continue as an advisor for a period following the […]

Filed Under: Business/Financial News, Featured Tagged With: AxoGen, Bonesupport, Cerus Corp., GI Dynamics, Insulet, Livongo, Medidata Solutions, Medtronic, pressaomedical, quantadialysistech, Reva Medical Inc., Senseonics, Smith & Nephew, taelifesciences, wrightmedical

Medtech veteran Reggie Groves on leading with ‘patients first’

January 7, 2019 By Sarah Faulkner

In guiding Medtronic through the Fidelis lead recall, medtech veteran Reggie Groves always took a “patients first” perspective. At DeviceTalks West 2018, Groves explained how her time at Medtronic influenced her as a leader and how she has brought those lessons into her role as CEO of Reva Medical. Once the world’s most popular defibrillator […]

Filed Under: Drug-Device Combinations, Featured, Recalls, Vascular, Wall Street Beat Tagged With: DeviceTalks West, Medtronic, Reva Medical Inc.

How Reggie Groves reinvented Medtronic’s atrial fibrillation biz

December 7, 2018 By Sarah Faulkner

Reva Medical (ASX:RVA) CEO Reggie Groves got her start in the medical device industry at medtech titan Medtronic. In her upcoming keynote interview at DeviceTalks West, Groves will discuss how that experience has shaped her as a leader and an innovator. Here’s a preview: When Reggie Groves joined Medtronic (NYSE:MDT) in 2002, she didn’t know very much […]

Filed Under: Business/Financial News, Cardiovascular, Featured, Vascular, Wall Street Beat Tagged With: DeviceTalks West, Johnson and Johnson, Medtronic, Reva Medical Inc., stjudemedical

Reva touts first implant of Fantom Encore bioresorbable scaffold in Italy

December 5, 2018 By Sarah Faulkner

Reva Medical (ASX:RVA) touted this week the first implant of its newly-launched Fantom Encore bioresorbable scaffold in Italy. The company’s third-generation coronary bioresorbable scaffold features a thin strut profile and Reva’s Tyrocore polymer. Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Drug-Device Combinations, Featured, Pharmaceutical, Vascular, Wall Street Beat Tagged With: Reva Medical Inc.

Sales for Reva Medical up in Q3 following launch of bioresorbable scaffold

November 6, 2018 By Sarah Faulkner

Shares in Reva Medical (ASX:RVA) rose today after the medical device maker posted its third-quarter financial results. The San Diego, Calif.-based company recorded a net loss of -$9 million on sales of $93,000 for the 3 months ended Sept. 30, for sales growth of 447% compared with the same period last year. Earnings per share were -22¢. […]

Filed Under: Drug-Device Combinations, MassDevice Earnings Roundup, Pharmaceutical, Vascular, Wall Street Beat Tagged With: Reva Medical Inc.

Reva launches Fantom Encore bioresorbable scaffold

November 1, 2018 By Sarah Faulkner

Reva Medical (ASX:RVA) said this week that it launched its Fantom Encore bioresorbable, drug-eluting scaffold and that the first person was treated in a post-market trial of the device. The Fantom Encore product is a third-gen coronary bioresorbable scaffold featuring a thin strut profile and Reva’s Tyrocore polymer. Get the full story at our sister site, […]

Filed Under: Drug-Device Combinations, Featured, Pharmaceutical, Vascular, Wall Street Beat Tagged With: Reva Medical Inc.

Reva wins CE Mark for bioresorbable scaffold in below-the-knee PAD

July 26, 2018 By Fink Densford

Reva Medical (ASX:RVA) said yesterday it won CE Mark approval in the European Union for its Motiv bioresorbable drug-eluting scaffold, now cleared for treatment of below-the-knee peripheral artery disease. The San Diego-based company’s Motiv is made from the company’s proprietary radiopaque Tyrocore polymer designed for vascular scaffolds. Reva said that over the coming months, it will […]

Filed Under: Drug-Device Combinations, Drug-Eluting Stents, Regulatory/Compliance, Stents, Vascular Tagged With: Reva Medical Inc.

  • Page 1
  • Page 2
  • Page 3
  • Interim pages omitted …
  • Page 5
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy